Skip to content

Inherited Metabolic Sample (Liquid Chromatography-Tandem Mass Spectrometry) Pretreatment System

by Bgi Europe a/S

Ref EU0200070001Model BGI LMSP-192

Active European Union

CE IVDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number574400351EU0200070001RN Basic UDI-DI 05744003510139UDI-DIDate18 Jul 2024RegisteredStatusActive

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Device Name
Inherited Metabolic Sample (Liquid Chromatography-Tandem Mass Spectrometry) Pretreatment System
Model / Reference
BGI LMSP-192, EU0200070001
Primary DI / UDI-DI
05744003510139
Basic UDI-DI
574400351EU0200070001RN
Direct Marketing DI
05744003510139
EMDN Code
W02069099 Various sample processing instruments - other
Device Class
Class A
EU market of registration
Denmark

Manufacturer details

EUDAMED SRN
DK-MF-000014089

Other devices from Bgi Europe a/S

See all devices from Bgi Europe a/S →

Properties

  • Professional Testing
  • Surgical Instrument

Other properties (9)

  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • New Device: No